SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING APLINDORE AND DERIVATIVES THEREOF
The present invention provides controlled release dosage formulations of compounds having the Formula (I) or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds. L'inven...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides controlled release dosage formulations of compounds having the Formula (I) or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
L'invention concerne des formulations posologiques à libération lente des composés possédant la formule (I) ou de leurs sels pharmaceutiquement acceptables et notamment de l'aplindore. Les formes posologiques sont utiles, entre autres, pour réduire les effets secondaires de l'administration de ces composés. |
---|